rs2811712: Understanding Genetic Associations with Physical Healthspan
The rs2811712 variant is a single nucleotide polymorphism located on chromosome 9. It has been identified in research studies as being associated with differences in physical function and healthspan as individuals age.
What each genotype means
Baseline healthspan profile
This genotype represents the major allele configuration in many populations. Research suggests this is the baseline state against which the potential protective effects of the minor allele are measured regarding late-life physical impairment.
This is the most common genotype in European populations, occurring in approximately 60% of individuals.
Potential healthspan benefit
Carrying one copy of the minor allele is associated in some aging cohorts with a reduced risk of late-life physical impairment. This suggests a potential contribution to enhanced functional healthspan, though the effect size is considered moderate and may vary by environmental factors.
Carried by roughly 1 in 3 people of European ancestry; it is less common in East Asian populations.
Enhanced healthspan profile
Individuals with two copies of the minor allele may experience the strongest association with reduced risk of late-life physical impairment. While this genotype is linked to better functional healthspan outcomes in specific studies, it is important to remember that lifestyle and other genetic factors also play significant roles in healthy aging.
This genotype is the least common, found in approximately 5% of individuals of European ancestry.
What is rs2811712 and Where is it Located?
The rs2811712 variant is a single nucleotide polymorphism, or SNP, which is a common type of genetic variation where a single building block of DNA—a nucleotide—is replaced by another. This specific SNP is located on chromosome 9 at position 21,998,036 (GRCh38). While some SNPs fall directly within the coding regions of genes, rs2811712 is situated within the CDKN2B-AS1 region. This area is often referred to as intergenic or regulatory, meaning it may play a role in controlling the activity of nearby genes rather than providing instructions for a specific protein itself. Because it is located in a non-coding region, researchers study it to understand how variations in these regulatory sequences might influence complex traits like physical health during the aging process.
Research Associations and Evidence Strength
Scientific research has investigated rs2811712 in the context of aging and physical health. Studies have observed statistical associations between this variant and the risk of experiencing physical impairment as people grow older. Specifically, individuals carrying the G allele have been noted in some cohorts to have a lower risk of physical decline compared to those with the A allele. It is important to note that the evidence strength for this association is considered moderate. While these findings are interesting, they are based on observational studies of specific populations. Genetic associations with complex traits like aging are rarely determined by a single variant; rather, they are the result of a combination of many genetic factors, environmental influences, and lifestyle choices. Therefore, this SNP should be viewed as one small piece of a much larger, complex puzzle.
What You Can and Cannot Do with This Information
Understanding your genotype for rs2811712 provides insight into your genetic makeup, but it does not serve as a medical diagnosis or a predictor of your future health. Because this variant is associated with complex, multi-factorial traits, it cannot be used to determine if you will or will not experience physical impairment. You cannot use this information to make medical decisions, change your diet, or alter your exercise routine without consulting a healthcare professional. Genetic testing for such variants is primarily for educational purposes and curiosity. If you have concerns about your physical health, mobility, or aging, the most effective approach is to speak with your doctor. They can provide personalized guidance based on your complete medical history, physical examinations, and established clinical markers, which are far more predictive of your health outcomes than any single genetic variant.
How common is this variant?
The minor allele frequency for rs2811712 is approximately 0.22 in European populations. Frequency data can vary significantly across different global ancestries.
Frequently asked questions
Is rs2811712 a diagnostic test for aging?
No, rs2811712 is not a diagnostic test. It is a genetic variant associated with statistical trends in physical healthspan, not a tool to predict individual health outcomes.
Can I change my risk associated with this SNP?
Genetic variants are fixed at birth. However, physical healthspan is heavily influenced by lifestyle factors such as nutrition, physical activity, and medical care, which you can manage.
Where can I find more information on this SNP?
You can explore databases like dbSNP or the GWAS Catalog for technical data. Always ensure you are looking at peer-reviewed research when evaluating genetic associations.
Should I be worried if I have the AA genotype?
No. Genetic associations are probabilistic, not deterministic. Many factors contribute to healthy aging, and a single SNP has a very limited impact on your overall health trajectory.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2811712?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
A genetic variant associated with the expression of the cathepsin B gene in blood, linked to extreme longevity phenotypes.
The G-allele of this variant has been associated with a positive impact on healthy lifespan in human cohorts.
A non-coding variant in the CDKN2B-AS1 locus associated with human longevity and survival beyond 90 years of age.
Variant in the APOE/APOC1 gene cluster linked to APOE isoform expression and studied for its role in neurocognitive healthspan and longevity.
Intronic regulatory polymorphism in SIRT3 modulating mitochondrial sirtuin pathways and studied in relation to survival and longevity phenotypes.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.